The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Shaanxi Panlong Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.46% CNY30.17
America/New_York / 6 mai 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 172.51 mill |
| EPS: | 1.200 |
| P/E: | 25.14 |
| Earnings Date: | May 21, 2024 |
| SharesOutstanding: | 105.15 mill |
| Avg Daily Volume: | 3.94 mill |
| RATING 2024-05-06 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.70x |
| Company: PE 25.14 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.55x |
| Company: PE 25.14 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY33.87 (12.26%) CNY3.70 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 28.56 - 30.88 ( +/- 3.92%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY30.17 (3.46% ) |
| Volume | 4.59 mill |
| Avg. Vol. | 3.94 mill |
| % of Avg. Vol | 116.65 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002864.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002864.SZ
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The company was founded in 1997 and is headquartered in Xi'an, China.